patients mostly require the assessment of induced sputum. Because of its limitations, several studies showed blood eosinophil count can potentially serve as respectable surrogate marker for sputum eosinophilic COPD.
characteristics and absolute eosinophil count was recorded. Quantitative variables were summarized as mean and standard deviation, while qualitative variables were tabulated as frequency and percentage. Correlation between eosinophil level and degree of COPD was graphically presented in a scatterplot and analyzed using Pearson's product Correlation.
Results: We analysed 102 stable COPD patients. There were 59(57.84%) eosinophilic COPD and 43(42.16%) non-eosinophilic COPD patients. The mean age was 69 years old, mostly males, 81.37%. The mean ages of both groups were 65.7 AE .9 and 62.1 AE .20 on COPD eosinophilic and non-eosinophilic patients respectively, P = 0.05. Both study groups have more male subjects, 52(88.14%) and 31(72%); however, there were more females in the non-eosinophilic compared to the eosinophilic group 12(27.9%) vs 7(11.6%),P = 0.04. A high pack years smoked was reported in the eosinophilic group compared to the noneosinophilic group (54. AE 2.0 vs 43.4 AE 7.90 correspondingly, P = 0.007). Correlation between absolute eosinophil value and the degree of COPD was weak (r = 0.3467), but statistically significant with P = 0.0004.
Conclusion: Absolute eosinophil levels above ≥0.40×109/L showed the possibility of increased risk for exacerbation in stable COPD patients. This study was able to ascertain that as the degree of COPD elevates, the levels of the eosinophil count is also increased. However, there was no established relationship between severity of airflow limitation and the level of eosinophil count. Background and Aims Introduction: Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide and is likely to increase during the next decades. However, nurses do not have sufficient updated knowledge to provide optimal care for patients with COPD. So, an updated COPD educational program was conducted. To improve COPD nursing care by enhancing nurse staff's knowledge in COPD. To standardized the nursing care provided for patients with COPD Objectives Methods: Updated Guidelines of COPD management from Global Initiative For COPD (GOLD) was introduced. Workshop was held to introduce the indications and uses of inhalation medications for COPD Re-demonstration of inhalation medications for COPD by nurses. COPD Bundles of Care were introduced Chronic Disease management Model was introduced on caring patients with COPD. An educational program and workshop on COPD Care was held, the contends are as below:
Results: The participants indicated that knowledge and skill enhancement contributed to professional development and strengthened the nurses' confidence in caring patients with COPD.
Conclusion:
The enhanced knowledge improved the nurses' confidence in performing nursing tasks and made the patients feel secure Implementing COPD education programmes for nurses is of importance in securing safer patient care. Methods: Recruited patients who met the COPD diagnostic criteria in a respiratory clinic and collected patient-related clinical information. According to patient's clinical characteristics, radiological report signs are divided into Chronic Bronchitis type (continuous cough, sputum, shortness of breath, imaging suggest chronic bronchitis signs, with or without signs of emphysema); Emphysema type (no or occasional cough, sputum, shortness of breath, radiographic evidence of emphysema); Asthma-COPD Overlap type (clinical diagnosis Asthma-COPD Overlap, imaging suggestive of chronic bronchitis). To compare the three groups of respiratory symptoms, pulmonary function, imaging signs, acute exacerbations within 12 months whether it's a significant difference.
Results: In this study, 357 COPD patients were enrolled, including 157 patients in Chronic Bronchitis type, 78 patients in Emphysema type, and 122 patients in Asthma-COPD Overlap type. The degree of lung function impairment in patients with chronic bronchitis was more severe than other two types (POST-FEV1%PRED 43.0 AE 7.75%, 50.0 AE 1.24% vs 56.8 AE 0.36%, F = 17.345, P = 0.00, POST-FEV1%FVC 42.2 AE 1.90%, 45.5 AE 1.23%, 49.5 AE 2.34%, F = 12.880, P = 0.02). Combined with the CAT score, the patients with Emphysema type subgroups were milder on the other two types (10. AE .4, vs 12.8 AE .0, 13.4 AE .4, F = 3.265, P = 0.03). However, on the comparison of acute exacerbations within 12 months, the times of acute exacerbations in patients with Emphysematous type in the past 12 months was higher than that in patients with Chronic Bronchitis (1.6 AE .25 vs 1.1 AE .10, P = 0.04).
The severity of lung function impairment and respiratory symptoms in patients with chronic bronchitis type were more severe than those other types. However, it was observed that patients in Emphysema type had higher rates of acute exacerbation than those with chronic bronchitis, which may be related to the absence or minimal respiratory symptoms. 
